Spread Through Air Spaces in Stage I Pulmonary Large Cell Neuroendocrine Carcinoma

CONCLUSIONS: STAS may serve as an adverse prognostic factor in stage I LCNEC patients, potentially offering guidance for postoperative chemotherapy decisions.PMID:38242341 | DOI:10.1016/j.athoracsur.2024.01.002
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Source Type: research